Dec 21, 2025
ROLE SUMMARY At Pfizer Oncology, we are committed to “Outdo Cancer” by advancing transformative medicines wherever we can make a profound difference in the lives of patients. Today, Pfizer Oncology has an industry-leading pipeline that includes the combined legacy Pfizer and Seagen portfolio across breast, genitourinary, hematology-oncology, thoracic and gastrointestinal therapeutic areas. The Global Commercial Oncology CDx Lead will drive commercial thought leadership on companion diagnostic global launch strategy for pre-launch oncology assets, including a potential first-in-class integrin-Beta-6 (IB6)-targeting antibody drug conjugate (ADC) sigvotatug vedotin (SV) (should a companion diagnostic be needed). The first commercial launch could potentially be in 2L+ NSCLC in 2027. The role requires demonstrated experience harmonizing commercial companion diagnostics global launch excellence and Rx launch strategy. Specific experience in global marketing, commercial...
Pfizer
New York, NY, USA